MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Monitoring dyskinesia severity using wearable sensor data

J.F. Daneault, F.N. Golabchi, S.I. Lee, G. Vergara-Diaz, G. Ferreira Carvalho, E. Fabara, S. Sapienza, P. Bonato (Charlestown, MA, USA)

Meeting: 2016 International Congress

Abstract Number: 560

Keywords: Dyskinesias, Wearing-off fluctuations

Session Information

Date: Tuesday, June 21, 2016

Session Title: Technology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: Herein we present the results of ongoing work focused on estimating limb-specific dyskinesia in patients with PD using wearable sensor data collected in the clinic.

Background: A major challenge in the management of Parkinson’s diseases (PD) is to accurately monitor the severity of PD symptoms over time. The development of wearable sensors has opened the door for long-term monitoring of patients in the home and community settings. There is a need for developing methods suitable to monitor the severity of PD symptoms in patients with PD in and outside the clinic.

Methods: The motor function of ten patients diagnosed with idiopathic PD was assessed clinically on a 0-4 scale and using wearable sensors to collect acceleration data during the performance of upper-limb tasks. The tasks were repeated 24 times at 30 minute intervals over 2 days. Predefined features were extracted from the acceleration data of the limbs not performing voluntary movements. Then, a feature selection algorithm was used to identify features relevant to the estimation of the clinical scores. Finally, clinical scores of dyskinesia were estimated using a cost-sensitive random forest algorithm. A leave-one-subject-out cross-validation technique was used to estimate the clinical scores.

Results: From the acceleration data, we were able to estimate limb-specific scores of dyskinesia. Mean absolute deviation for the left arm, right arm, left leg, and right leg scores were 0.40, 0.29, 0.38, and 0.39, respectively.

Conclusions: The preliminary results of this study demonstrate the feasibility of estimating the severity of dyskinesia using wearable sensor data. While additional work is required to improve the accuracy of the estimation procedures, this work highlights the possibility of remotely assessing the severity of PD symptoms in patients with PD.

To cite this abstract in AMA style:

J.F. Daneault, F.N. Golabchi, S.I. Lee, G. Vergara-Diaz, G. Ferreira Carvalho, E. Fabara, S. Sapienza, P. Bonato. Monitoring dyskinesia severity using wearable sensor data [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/monitoring-dyskinesia-severity-using-wearable-sensor-data/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/monitoring-dyskinesia-severity-using-wearable-sensor-data/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley